Tower Research Capital (TRC)’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3
| Closed | -$5 | – | 5415 |
|
|
2025
Q1 | $5 | Buy |
+3
| New | +$5 | ﹤0.01% | 5113 |
|
|
2023
Q1 | – | Sell |
-2,954
| Closed | -$11K | – | 6055 |
|
|
2022
Q4 | $11K | Buy |
+2,954
| New | +$11K | ﹤0.01% | 3826 |
|
|
2022
Q3 | – | Sell |
-2,600
| Closed | -$7K | – | 6271 |
|
|
2022
Q2 | $7K | Buy |
+2,600
| New | +$7K | ﹤0.01% | 4799 |
|
|
2022
Q1 | – | Sell |
-410
| Closed | -$2K | – | 6310 |
|
|
2021
Q4 | $2K | Sell |
410
-6,800
| -94% | -$33.2K | ﹤0.01% | 5633 |
|
|
2021
Q3 | $44K | Buy |
+7,210
| New | +$44K | ﹤0.01% | 3060 |
|
|
2020
Q1 | – | Sell |
-937
| Closed | -$6K | – | 3466 |
|
|
2019
Q4 | $6K | Buy |
+937
| New | +$6K | ﹤0.01% | 2596 |
|